ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

HCM.GB HUTCHMED China Limited

310.00
0.00 (0.00%)
15:56:11 - Realtime Data
Share Name Share Symbol Market Stock Type
HUTCHMED China Limited HCM.GB Aquis Stock Exchange Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 310.00 15:56:11
Open Price Low Price High Price Close Price Previous Close
310.00 310.00 310.00 310.00
more quote information »

Recent News

Date Time Source Heading
11/1/202418:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
29/12/202319:30UKREGHutchmed (China) Limited Total Voting Rights
29/12/202319:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
21/12/202321:00UKREGHutchmed (China) Limited Overseas Regulatory Announcement
13/12/202318:00RNSNONHutchmed (China) Limited Inclusion in National Reimbursement..
07/12/202321:04UKREGHutchmed (China) Limited Overseas Regulatory Announcement
01/12/202318:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
30/11/202319:30UKREGHutchmed (China) Limited Total Voting Rights
09/11/202318:00UKREGHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM)..
24/10/202319:30UKREGHutchmed (China) Limited Vesting of awards under the LTIP
16/10/202319:30RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
29/9/202318:30RNSNONHutchmed (China) Limited NDA Submission for Fruquintinib in..
29/9/202318:30UKREGHutchmed (China) Limited Total Voting Rights
14/9/202318:30UKREGHutchmed (China) Limited Director's Share Dealing
12/9/202318:30RNSNONHutchmed (China) Limited Phase IIIb Savolitinib Results at..
12/9/202316:00RNSNONHutchmed (China) Limited Patient Enrollment Completed for..
31/8/202318:30UKREGHutchmed (China) Limited Total Voting Rights
29/8/202316:00RNSNONHutchmed (China) Limited BTD in China for Savolitinib for..
21/8/202316:00UKREGHutchmed (China) Limited Sovleplenib Phase 3 Study Meets..
07/8/202318:30UKREGHutchmed (China) Limited Exercise of Share Options by a..
31/7/202321:00UKREGHutchmed (China) Limited Interim Results and Business..
20/7/202316:00RNSNONHutchmed (China) Limited Breakthrough Therapy Designation..
13/7/202318:30UKREGHutchmed (China) Limited Changes to Board and Technical..
10/7/202316:00RNSNONHutchmed (China) Limited Phase 1 Study of HMPL-415 Initiated
29/6/202318:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
26/6/202318:30UKREGHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year..
16/6/202316:00UKREGHutchmed (China) Limited Phase III FRESCO-2 Results in The..
16/6/202300:39UKREGHutchmed (China) Limited MAA of Fruquintinib Validated by..
09/6/202319:30RNSNONHutchmed (China) Limited HUTCHMED Highlights Presentations..
06/6/202319:00UKREGHutchmed (China) Limited LTIP and Share Option Scheme
31/5/202318:30UKREGHutchmed (China) Limited Total Voting Rights
26/5/202316:00RNSNONHutchmed (China) Limited HUTCHMED Highlights Presentations..
26/5/202316:00UKREGHutchmed (China) Limited Fruquintinib NDA Granted Priority..
17/5/202318:30UKREGHutchmed (China) Limited Standard form for notification of..
12/5/202322:15UKREGHutchmed (China) Limited Annual General Meeting Poll Results
12/5/202318:30UKREGHutchmed (China) Limited Board of Directors and Board..
10/5/202318:30UKREGHutchmed (China) Limited Appointment of Independent NED

Your Recent History

Delayed Upgrade Clock